CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 55 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,711,000 | -32.2% | 810,693 | -7.2% | 0.00% | – |
| Q1 2021 | $2,524,000 | +43.2% | 873,510 | +6.1% | 0.00% | – |
| Q4 2020 | $1,762,000 | -65.0% | 823,518 | +1.4% | 0.00% | – |
| Q3 2020 | $5,029,000 | +5.0% | 812,230 | +9.1% | 0.00% | – |
| Q2 2020 | $4,790,000 | +70.8% | 744,788 | +10.2% | 0.00% | – |
| Q1 2020 | $2,805,000 | +12.5% | 675,941 | +60.2% | 0.00% | – |
| Q4 2019 | $2,493,000 | +9.4% | 421,814 | 0.0% | 0.00% | – |
| Q3 2019 | $2,278,000 | -31.9% | 421,814 | +1.7% | 0.00% | – |
| Q2 2019 | $3,347,000 | +18.2% | 414,748 | +16.0% | 0.00% | – |
| Q1 2019 | $2,832,000 | +162.2% | 357,593 | +44.7% | 0.00% | – |
| Q4 2018 | $1,080,000 | – | 247,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
| XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
| Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
| Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
| Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
| Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
| Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
| WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |